Ipsen's medicines are registered in more than 100 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world.
In over 100 countries, Ipsen registers its medicines for direct commercial use, and it operates four global research and development centers alongside three pharmaceutical development sites globally.